{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:57:05Z","timestamp":1790575025614,"version":"4.1.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer, yet reliable biomarkers for stratifying early-stage patients at high risk of progression and poor prognosis remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled 168 LUAD patients who underwent surgery at The Fourth Hospital of Hebei Medical University. ATF4 and SLC7A11 expressions were assessed by immunohistochemistry. Associations with clinicopathological features were evaluated by \u03c7\u00b2\/Fisher\u2019s exact tests; univariate and multivariate Cox regression analyses of overall survival (OS) and metastasis-free survival (MFS) were performed, and model discrimination was quantified by the concordance index (C-index).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ATF4 was nuclear-positive in 55.4% of tumors, and SLC7A11 was cytoplasmic-positive in 59.5% of tumors. Neither ATF4 nor SLC7A11 was positively expressed in the stromal cells. The expression of ATF4 and SLC7A11 in tissues with pathological necrosis was enhanced. Both ATF4 and SLC7A11 correlated with aggressive features (more aggressive pathological subtypes with malignant potential, advanced clinical stage, lymph node metastasis, poor differentiation, pleural invasion, and pathological necrosis). ATF4 expression was also associated with lymphatic\/vascular invasion. ATF4 (HR\u00a0=\u00a01.533, 95% CI, 1.040-2.259;\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.031) and SLC7A11 (HR\u00a0=\u00a01.527, 95% CI, 1.013-2.303;\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.043) were both independent prognostic factors for OS. As a combined indicator, ATF4 and SLC7A11 can enhance the C-index of the prognostic prediction model, and either positive for ATF4 or SLC7A11 have the highest C-index, regardless of whether it is for OS or MFS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ATF4\/SLC7A11 are clinically useful prognostic biomarkers in LUAD. Either ATF4- or SLC7A11-positive expression appears to yield enhanced predictive value and may help identify high-risk patients for intensified surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1969897","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:43:51Z","timestamp":1790574231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Yanjie","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Guo","sequence":"additional","affiliation":[{"name":"Cancer Institute, Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojuan","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Institute, Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[{"name":"Cancer Institute, Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4065\/83.5.584","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/crj.70107","article-title":"Comprehensive analysis of lung cancer metastasis: Sites, rates, survival, and risk factors-a systematic review and meta-analysis","volume":"19","author":"Wang","year":"2025","journal-title":"Clin Respir J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052049","article-title":"Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature)","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.lungcan.2021.07.001","article-title":"Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis","volume":"159","author":"Oiwa","year":"2021","journal-title":"Lung Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.21037\/jtd-21-1597","article-title":"Clinical significance of tumor necrosis and viability in non-small cell lung cancer","volume":"14","author":"Moon","year":"2022","journal-title":"J Thorac Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","article-title":"Surviving stress: Modulation of ATF4-mediated stress responses in normal and malignant cells","volume":"28","author":"Wortel","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.016","article-title":"ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis","volume":"79","author":"He","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.146","article-title":"ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1821323116","article-title":"Cystine\/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance","volume":"116","author":"Lim","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2174\/156652409788167096","article-title":"ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis","volume":"9","author":"Ye","year":"2009","journal-title":"Curr Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1859","article-title":"Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells","volume":"103","author":"Ameri","year":"2004","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.43167","article-title":"ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt\/\u03b2-catenin signaling","volume":"18","author":"Du","year":"2021","journal-title":"Int J Med Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0307-z","article-title":"xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression","volume":"37","author":"Ji","year":"2018","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-023-05719-x","article-title":"PDIA4 confers resistance to ferroptosis via induction of ATF4\/SLC7A11 in renal cell carcinoma","volume":"14","author":"Kang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0353653","article-title":"Sodium butyrate induces mitochondrial pathway apoptosis in liver cancer via ATF4\/SLC7A11-mediated ferroptosis","volume":"21","author":"Meng","year":"2026","journal-title":"PloS One"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1969897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:43:52Z","timestamp":1790574232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1969897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":17,"alternative-id":["10.3389\/fonc.2026.1969897"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1969897","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1969897"}}